Schizophrenia Program of the Massachusetts General Hospital, Freedom Trail Clinic, 25 Staniford St
Boston, Massachusetts, 02114, United States
NCT Number: NCT01982617
The investigators primary hypothesis was that recipients of the Motivational Interviewing intervention would be significantly more likely than those assigned to the Psychoeducation intervention to demonstrate increased readiness to quit smoking at the end of the intervention and to seek smoking cessation treatment in the one month period following the intervention. We also predicted that the Psychoeducation intervention would result in greater improvements in smoking knowledge.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 30 days
efficacy of a cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention in terms of promoting increased readiness to quit smoking among smokers with severe mental illness who were not ready to quit.
Time frame: 30 days
Changes in smoking knowledge obtained through cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention
Massachusetts General Hospital
Other
A Randomized, Controlled Trial of Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With Severe Mental Illness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01412866
Behavior, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT01783912
Behavior, Chemically-Induced Disorders
Madison, Wisconsin, United States
View Trial DetailsNCT01204723
Cannabis Abuse, Cannabis Dependence
Charlottesville, Virginia, United States
View Trial DetailsNCT07466875
Anxiety, Anxiety Disorders
Nantou City, Taiwan
View Trial Details